Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2395 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

EyeGate Pharma completes Phase II dry eye trial

EyeGate Pharma, a specialty pharmaceutical company, has fully enrolled and completed all follow-up visits for all patients participating in its Phase II safety and efficacy study of EGP-437,

Biolase names new CEO

Mr Mulder replaces Jake Philip, who has resigned his positions as CEO and director of the company to pursue other interests. Previously, Mr Mulder served for two years

Oxygen Biotherapeutics and VCU to form new joint venture

Oxygen Biotherapeutics, a developer of biotechnology products, and Virginia Commonwealth University have signed a memorandum of understanding to establish a federal defense appropriation-funded joint venture focusing on developing

Sysmex announces senior management changes

Effective April 1, 2009, Kazuya Obe will return to Sysmex Corporate after a six-year tenure in the US and serve in an international business leadership position. He will